Results
1 -
10 of
98Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors, Heart Failure Reviews GLP-1R activation for the treatment of stroke: Updating and future perspectives, Reviews in Endocrine and Metabolic Disorders IQWiG zeigt wenig Gnade, CME Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials, Advances in Therapy Haben Innovationen in der Diabetestherapie bei uns noch eine Chance?, Info Diabetologie The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs, Diabetes Therapy Advances in Pharmacologic Therapies for Type 2 Diabetes, Current Atherosclerosis Reports Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature, Endocrine Haben Innovationen bei uns noch eine Chance?, MMW - Fortschritte der Medizin